1. Home
  2. SHIP vs TTRX Comparison

SHIP vs TTRX Comparison

Compare SHIP & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seanergy Maritime Holdings Corp.

SHIP

Seanergy Maritime Holdings Corp.

HOLD

Current Price

$17.63

Market Cap

335.9M

ML Signal

HOLD

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

N/A

Current Price

$11.39

Market Cap

298.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SHIP
TTRX
Founded
2008
2015
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
335.9M
298.8M
IPO Year
2008
2025

Fundamental Metrics

Financial Performance
Metric
SHIP
TTRX
Price
$17.63
$11.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$23.25
★ $25.00
AVG Volume (30 Days)
★ 405.8K
131.9K
Earning Date
11-12-2026
11-25-2026
Dividend Yield
★ 2.49%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$27.31
N/A
Revenue Next Year
N/A
$900.00
P/E Ratio
$13.34
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.66
$2.57
52 Week High
$19.22
$16.45

Technical Indicators

Market Signals
Indicator
SHIP
TTRX
Relative Strength Index (RSI) 51.78 43.50
Support Level $15.92 $9.02
Resistance Level $19.20 $14.39
Average True Range (ATR) 0.61 1.44
MACD -0.04 -0.42
Stochastic Oscillator 49.02 1.44

Price Performance

Historical Comparison
SHIP
TTRX

About SHIP Seanergy Maritime Holdings Corp.

Seanergy Maritime Holdings Corp is an international shipping company that provides marine dry bulk transportation services through a modern fleet of Capesize vessels. It generates a majority of its revenue from the vessels. The company's fleet of vessels includes Blueship, Meiship, Kaizenship, Iconship, Titanship, Flagship, Paroship, Worldship, Hellasship, Partnership, Championship, Patriotship, Dukeship, Honorship, Fellowship, Knightship, Lordship, Premiership, Squireship, and Friendship.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: